NYSE$DOCS

Doximity Inc. · Q4 2023 earnings

Q4 2023 earnings · · Investor relations

Briefing

Reported Q4 2023 financial results, showing revenue growth and profitability.

Doximity announced its Q4 2023 financial results, featuring an 18% year-over-year increase in revenue to $111.0 million and a net income of $30.7 million, representing a 28% margin. The company also appointed Craig Overpeck as SVP of commercial operations and Ben Greenberg as SVP of commercial products.

  • Q4 total revenues reached $111.0 million, an 18% increase year-over-year.
  • Net income margin for Q4 was 28%, while adjusted EBITDA margin was 44%.
  • Craig Overpeck and Ben Greenberg were appointed as new senior leadership members.
  • A record number of providers used Doximity's physician cloud in Q4.

Headline financials

Total Revenue

$111M

Previous: $93.7M+18.5%
EPS (adj)

$0.20

Previous: $0.21-4.8%
Capital Expenditures

$21K

Previous: $1.06M-98.0%
Free Cash Flow

$45.6M

Previous: $45.9M-0.7%
Net Income

$30.7M

Previous: $36.7M-16.4%
Operating Income

$32.8M

Previous: $27.9M+17.6%
Gross Profit

$97.3M

Previous: $81.9M+18.8%
Cash & Equivalents

$158M

Previous: $113M+40.1%
Total Assets

$1.14B

Previous: $991M+14.7%
Stock-Based Comp

$13M

Previous: $9.81M+32.4%

Revenue & EPS history

Doximity · Revenue · Quarterly

$111M

Q4 2023+18.5%vs Q4 2022
Beat estimate in 13 of 14 quarters(93%)
ActualEstimate

Forward guidance

Doximity provided revenue and adjusted EBITDA guidance for the fiscal first quarter ending June 30, 2023, and for the fiscal year ending March 31, 2024.

Tailwinds

  • Revenue between $106.5 million and $107.5 million for the fiscal first quarter ending June 30, 2023.
  • Adjusted EBITDA between $39.0 million and $40.0 million for the fiscal first quarter ending June 30, 2023.
  • Revenue between $500 million and $506 million for the fiscal year ending March 31, 2024.
  • Adjusted EBITDA between $216 million and $222 million for the fiscal year ending March 31, 2024.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 19 quarterly earnings reports · overlaid with Q4 2023

Historical avgQ4 2023

+5.5%

Avg return

Earnings day

+2.9%

Avg return

5 days after

+3.3%

Avg return

30 days after

64%

14 / 22 earnings

Positive

+45.6%

Q2 2023

Best reaction

-26.6%

Q1 2024

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q4 2026+5.3%-17.6%-14.3%
Q3 2026-16.8%-22.1%-23.9%
Q2 2026-13.0%-18.6%-26.6%
Q1 2026+13.4%+9.3%+18.4%
Q4 2025-10.1%-13.2%-4.3%
Q3 2025+36.0%+29.0%+9.8%
Q4 2024+17.5%+18.1%+25.2%
Q3 2024+4.3%+5.9%+1.9%
Q2 2024+13.1%+20.6%+16.3%
Q1 2024-26.6%-30.9%-31.6%
Q4 2023-6.4%-6.2%-5.2%
Q3 2023-14.9%-11.0%-22.0%
Q2 2023+45.6%+36.6%+48.5%
Q1 2023-11.1%-13.1%-22.2%
Q4 2020+3.2%+4.7%+22.3%
Q4 2022-8.1%-4.3%-1.9%
Q3 2021+21.1%+13.9%-6.8%
Q3 2022+27.3%+16.1%+2.9%
Q2 2021+0.2%-7.5%-29.5%
Q2 2022+1.4%+3.4%-19.1%
Q4 2021+8.0%+7.8%+44.9%
Q1 2022+31.5%+41.9%+89.2%
Q1 2021
Q3 2020

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro